APA

Retlich S., Duval V., Ring A., Staab A., Hüttner S., Jungnik A., Jaehde U., Dugi K. A. & Graefe-Mody U. (20110210). Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects. : Clinical pharmacokinetics.

Chicago

Retlich Silke, Duval Vincent, Ring Arne, Staab Alexander, Hüttner Silke, Jungnik Arvid, Jaehde Ulrich, Dugi Klaus A and Graefe-Mody Ulrike. 20110210. Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects. : Clinical pharmacokinetics.

Harvard

Retlich S., Duval V., Ring A., Staab A., Hüttner S., Jungnik A., Jaehde U., Dugi K. A. and Graefe-Mody U. (20110210). Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects. : Clinical pharmacokinetics.

MLA

Retlich Silke, Duval Vincent, Ring Arne, Staab Alexander, Hüttner Silke, Jungnik Arvid, Jaehde Ulrich, Dugi Klaus A and Graefe-Mody Ulrike. Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects. : Clinical pharmacokinetics. 20110210.